Information management has become an integral part of the European Medicines Agency's (EMA) mission to promote and protect public and animal health. This is driven by the increasing importance of interconnected information technology (IT) systems for managing and sharing information on medicines, the growing range of EMA's external users with different information requirements and the overall digital transformation of society and regulation.
The European medicines regulatory network relies on IT services to support all activities related to the authorisation and supervision of human and veterinary medicines in the European Union (EU). EMA makes available and maintains many of these IT services.
EMA staff and experts need IT solutions from EMA to carry out their core regulatory work. Many external stakeholders also increasingly rely on EMA's IT systems.
Pharmaceutical companies expect IT systems that help them meet their regulatory requirements more efficiently and cost-effectively.
Patients and healthcare professionals demand timely access to public information on medicines, so they can make their own decisions.
The globalisation of medicines means that EMA needs to share more information with regulatory authorities worldwide.
Academic sponsors rely on EMA's services, and the information EMA holds is also relevant for academic research.
Information management strategy
Update: EMA revised its Information Management Strategy in December 2018, taking into account changes in its operating environment and priorities:
The strategy focuses on optimising EMA's IT infrastructure and information services and driving the overall digital transformation of EMA. It was first adopted by EMA's Management Board in December 2015.